Metformin Hydrochloride Tablet, Extended Release
Product Images NDC 51655-077

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Metformin Hydrochloride (NDC 51655-077). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51655-077-52 (51655 077 52 Rev A 10 22)

51655-077-52 (51655 077 52   Rev A 10 22)
Metformin Hydrochloride Extended-Release Tablets, USP 750 mg, 30 tablets bottle label. The label includes storage instructions, cautions, and repackaging information. Manufactured by Northwind Pharmaceuticals in Indianapolis, IN.*
FDA Label Image

Structure (Metformin Struct)

Structure (Metformin Struct)
Chemical structure of Metformin Hydrochloride showing its molecular configuration with methyl groups, nitrogen atoms, and hydrochloride component, depicted with standard chemical notation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.